Operating
Change in Other Liabilities
Moderna Change in Other Liabilities increased by 123.2% to $26M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.2%, from $33M to $26M. Over 2 years (FY 2022 to FY 2024), Change in Other Liabilities shows an upward trend with a -67.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
Significant fluctuations may indicate changes in tax positions, litigation reserves, or other non-operating liabilities.
Detailed definition
Represents the net change in miscellaneous short-term or long-term obligations not captured in specific categories like...
Peer comparison
Varies significantly by company based on accounting classification policies.
Metric ID:
change_in_other_liabilitiesHistorical Data
18 periods
| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $60M | $100M | $35M | $228M | $10M | -$1.01B | -$15M | -$3M | $39M | $67M | $119M | -$186M | $4M | $141M | $33M | -$58M | -$112M | $26M |
| QoQ Change | — | +66.7% | -65.0% | +551.4% | -95.6% | <-999% | +98.5% | +80.0% | >999% | +71.8% | +77.6% | -256.3% | +102.2% | >999% | -76.6% | -275.8% | -93.1% | +123.2% |
| YoY Change | — | — | — | +280.0% | — | <-999% | -142.9% | -101.3% | +290.0% | +106.6% | +893.3% | <-999% | -89.7% | +110.4% | -72.3% | +68.8% | <-999% | -21.2% |
Range-$1.01B – $228M
CAGR-17.9%
Avg YoY Growth-627.9%
Median YoY Growth-46.7%
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Moderna's change in other liabilities?
- Moderna (MRNA) reported change in other liabilities of $26M in Q1 2026.
- How has Moderna's change in other liabilities changed year-over-year?
- Moderna's change in other liabilities decreased by 21.2% year-over-year, from $33M to $26M.
- What is the long-term trend for Moderna's change in other liabilities?
- Over 2 years (2022 to 2024), Moderna's change in other liabilities has grown at a -67.5% compound annual growth rate (CAGR), from -$740M to $78M.
- What does change in other liabilities mean?
- The change in miscellaneous debts and obligations not categorized elsewhere.